KVUE Share Price Performance
KVUE Community Fair Values
- US$23.80FV9.3% undervalued intrinsic discount3.01%Revenue growth p.a.0users have liked this narrative0users have commented on this narrative30users have followed this narrative3 days ago author updated this narrative
- US$25.09FV14.0% undervalued intrinsic discount8.70%Revenue growth p.a.1users have liked this narrative0users have commented on this narrative3users have followed this narrative9 months ago author updated this narrative
Recent KVUE News & Updates
No updates
Kenvue Inc. Key Details
Last Reported Earnings
Mar 30, 2025
Next Reporting Earnings
Aug 07, 2025
- Earnings per share (EPS)
- 0.55
- Gross Margin
- 58.24%
- Net Profit Margin
- 6.90%
- Debt/Equity Ratio
- 86.9%
Kenvue Inc. Competitors
About KVUE
- Founded
- 2022
- Employees
- 22000
- CEO
- WebsiteView website
Kenvue Inc. operates as a consumer health company in the United States, Europe, the Middle East, Africa, Asia-Pacific, and Latin America. It operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee’s, ORSLTM, Rhinocort, Calpol, and Zyrtec brands. Its Skin Health and Beauty segment provides face and body care, hair, sun, and other care products under the Neutrogena, Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Rogaine, and OGX brand names. The Essential Health segment offers oral and baby, women’s health, wound, and other care products under the Listerine, Johnson’s, Band-Aid, and Stayfree, o.b., tampons, Carefree, and Desitin Diaper Rash brands. Kenvue Inc. was incorporated in 2022 and is headquartered in Summit, New Jersey.
U.S. Market Performance
- 7 Days: -2.7%
- 3 Months: 10.1%
- 1 Year: 17.7%
- Year to Date: 5.9%
Over the past 7 days, the market has dropped 2.7% with the Financials sector contributing the most to the decline. In the last year, the market is actually up 18%. Looking forward, earnings are forecast to grow by 15% annually. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading